Chemotherapy-induced hand-foot syndrome and nail changes are common complications of many classic chemotherapeutic agents and the newer molecular targeted therapies. They significantly impact patient quality of life, and frequently necessitate chemotherapy dose intensity modification or reduction. We aim to describe the epidemiology, pathogenesis, clinical presentation, and current evidence-based treatment options for these entities.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jaad.2014.03.019 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!